Menten AI
Entity
Description
  • Value proposition

    Building the world's most advanced generative AI platform for peptide therapeutics design.

    Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics.

Corporate interactions BETA
Corporate TypeTweets Articles
Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing 		Other

3 Jun 2024


Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing 		Other

25 Jan 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing 		Other

25 Jan 2024


Amazon Web Services (AWS)
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting 		Other

31 Aug 2021


Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion 		Other

31 May 2022


Volkswagen Group
Volkswagen Group
Automobile, Motor Vehicle Manufacturing
Volkswagen Group
Automobile, Motor Vehicle Manufacturing 		Other

31 Mar 2020


Accenture
Accenture
Consulting, audit, Business Consulting and Services
Accenture
Consulting, audit, Business Consulting and Services 		Other

29 Oct 2020


Microsoft
Microsoft
IT services, Software Development
Microsoft
IT services, Software Development 		Not capitalistic
Not partnership
Event

31 Mar 2020


Y Combinator
Y Combinator
Startup accelerator & VC, Venture Capital and Private Equity Principals
Y Combinator
Startup accelerator & VC, Venture Capital and Private Equity Principals 		Capitalistic
Partnership
Event

13 Apr 2020


Similar entities
Last news
Show all articles
Social network dynamics